- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 6.00 Å
- Oligo State
- hetero-2-2-2-2-2-2-mer
- Ligands
- 4 x FUC- BGC: beta-D-glucopyranose-(1-3)-alpha-L-fucopyranose(Post Translational Modification)
- 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.7: 2 residues within 4Å:- Chain E: N.63, A.481
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 2 residues within 4Å:- Chain E: N.178
- Chain F: N.191
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 3 residues within 4Å:- Chain G: N.63, K.480, A.481
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 4 residues within 4Å:- Chain G: P.148, E.149, N.178
- Chain H: N.191
1 PLIP interactions:1 interactions with chain G- Hydrophobic interactions: G:P.148
NAG-NAG.11: 3 residues within 4Å:- Chain I: S.25, N.26, P.173
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 2 residues within 4Å:- Chain I: W.118, N.119
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 4 residues within 4Å:- Chain J: S.25, N.26, P.173, V.196
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 2 residues within 4Å:- Chain J: W.118, N.119
No protein-ligand interaction detected (PLIP)- 18 x MAN: alpha-D-mannopyranose(Post Translational Modification)
MAN.15: 4 residues within 4Å:- Chain A: S.54, L.55, W.56, R.73
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:S.54, A:W.56, A:R.73, A:R.73
MAN.16: 2 residues within 4Å:- Chain A: T.58, W.59
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:S.57, A:T.58, A:T.58, A:W.59
MAN.17: 4 residues within 4Å:- Chain B: D.65, S.66, W.67, R.92
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:D.65, B:W.67, B:R.92, B:R.92
MAN.18: 5 residues within 4Å:- Chain B: G.68, E.69, W.70, R.114, W.178
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:W.70, B:W.70, B:R.114
MAN.19: 4 residues within 4Å:- Chain B: S.127, W.128, R.151, E.186
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:S.127, B:W.128, B:W.128, B:R.151, B:E.186, B:E.186
MAN.20: 4 residues within 4Å:- Chain B: S.132, T.133, W.134, R.147
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.132, B:W.134, B:R.147
MAN.21: 2 residues within 4Å:- Chain B: E.130, W.131
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:E.130, B:E.130, B:W.131, B:W.131, B:R.149
MAN.22: 6 residues within 4Å:- Chain B: G.5, W.6, R.28, C.42, A.43
- Ligands: MAN.23
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:W.6, B:R.28, B:R.28, B:C.42
MAN.23: 5 residues within 4Å:- Chain B: G.7, P.8, W.9, R.48
- Ligands: MAN.22
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:W.9, B:W.9, B:R.48
MAN.24: 4 residues within 4Å:- Chain C: S.54, L.55, W.56, R.73
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:W.56, C:W.56, C:R.73, C:R.73
MAN.25: 2 residues within 4Å:- Chain C: T.58, W.59
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:S.57, C:T.58, C:T.58, C:W.59
MAN.26: 4 residues within 4Å:- Chain D: D.65, S.66, W.67, R.92
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:D.65, D:W.67, D:R.92, D:R.92
MAN.27: 5 residues within 4Å:- Chain D: G.68, E.69, W.70, R.114, W.178
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:W.70, D:W.70, D:R.114, D:W.178
MAN.28: 6 residues within 4Å:- Chain D: G.126, S.127, W.128, R.151, C.185, E.186
6 PLIP interactions:6 interactions with chain D- Hydrogen bonds: D:S.127, D:W.128, D:W.128, D:R.151, D:E.186, D:E.186
MAN.29: 4 residues within 4Å:- Chain D: S.132, T.133, W.134, R.147
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:S.132, D:W.134, D:R.147
MAN.30: 3 residues within 4Å:- Chain D: E.130, W.131, R.149
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:W.131, D:W.131, D:R.149, D:R.149
MAN.31: 6 residues within 4Å:- Chain D: G.5, W.6, R.28, C.42, A.43
- Ligands: MAN.32
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:W.6, D:R.28, D:R.28, D:C.42
MAN.32: 5 residues within 4Å:- Chain D: G.7, P.8, W.9, R.48
- Ligands: MAN.31
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:G.7, D:W.9, D:R.48, D:R.48
- 2 x MG: MAGNESIUM ION(Non-covalent)
MG.33: 6 residues within 4Å:- Chain F: N.915
- Chain J: D.17, S.19, S.21, T.94, D.130
4 PLIP interactions:3 interactions with chain J, 1 interactions with chain F- Metal complexes: J:S.19, J:S.21, J:T.94, F:N.915
MG.34: 6 residues within 4Å:- Chain H: N.915
- Chain I: D.17, S.19, S.21, T.94, D.130
3 PLIP interactions:3 interactions with chain I- Metal complexes: I:S.19, I:S.21, I:T.94
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pedersen, D.V. et al., Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System. Front Immunol (2019)
- Release Date
- 2019-08-21
- Peptides
- Properdin: AC
Properdin: BD
Complement C3: EG
Complement C3: FH
Complement factor B: IJ
Inhibitor: KL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
UC
XB
VD
YE
AG
GF
BH
HI
JJ
LK
NL
Q
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 6.00 Å
- Oligo State
- hetero-2-2-2-2-2-2-mer
- Ligands
- 4 x FUC- BGC: beta-D-glucopyranose-(1-3)-alpha-L-fucopyranose(Post Translational Modification)
- 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 18 x MAN: alpha-D-mannopyranose(Post Translational Modification)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pedersen, D.V. et al., Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System. Front Immunol (2019)
- Release Date
- 2019-08-21
- Peptides
- Properdin: AC
Properdin: BD
Complement C3: EG
Complement C3: FH
Complement factor B: IJ
Inhibitor: KL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
UC
XB
VD
YE
AG
GF
BH
HI
JJ
LK
NL
Q